Stockreport

$207B Market Shift: The Race for Fast Track Approval in Oncology [Globe and Mail, The (Toronto, Canada)]

Oncolytics Biotech Inc. - Common Shares  (ONCY) 
Last oncolytics biotech inc. - common shares earnings: 11/12 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.oncolyticsbiotech.com
PDF In 2025 alone, the agency issued over 50 oncology approvals [1] , but the real story is the aggressive pivot toward targeted therapies for high-unmet-need solid tumors. [Read more]